Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada flag Canada · Delayed Price · Currency is CAD
0.1300
-0.0100 (-7.14%)
At close: Mar 20, 2026

Voyageur Pharmaceuticals Balance Sheet

Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20
Cash & Equivalents
0.940.1700.030.810
Cash & Short-Term Investments
0.940.1700.030.810
Cash Growth
30975.95%7840.96%-93.39%-96.12%27300.30%-96.08%
Accounts Receivable
0.120.050.040.020.040.01
Total Trade Receivables
0.120.050.040.020.040.01
Inventory
0.150.070.010.010.010.01
Other Current Assets
0.050.070.040.090.02-
Total Current Assets
1.260.360.090.160.890.03
Net Property, Plant & Equipment
000.010.010.030.02
Other Long-Term Assets
2.412.242.071.931.651.23
Total Assets
3.682.62.162.12.571.28
Accounts Payable
1.951.930.670.590.580.66
Short-Term Debt
-----0.21
Current Portion of Leases
----0.020.01
Other Current Liabilities
0.230.17--0.020.02
Total Current Liabilities
2.182.090.670.590.620.91
Long-Term Debt
0.040.040.040.030.030.03
Long-Term Leases
-----0.01
Other Long-Term Liabilities
0.010.010.010.010.010.01
Total Long-Term Liabilities
0.050.050.050.040.040.06
Total Liabilities
2.242.150.730.630.660.97
Common Stock
12.569.148.697.556.333.44
Additional Paid-in Capital
2.372.131.861.641.550.79
Accumulated Other Comprehensive Income
0.010.020.01---
Retained Earnings
-13.5-10.84-9.13-7.73-5.97-3.92
Shareholders' Equity
1.440.451.441.461.910.31
Total Liabilities & Equity
3.682.62.162.12.571.28
Total Debt
0.040.040.040.030.040.27
Net Cash (Debt)
0.90.13-0.040.010.77-0.27
Net Cash Growth
619.25%---99.22%--
Net Cash Per Share
0.010.00--0.01-0.00
Book Value
1.440.451.441.461.910.31
Book Value Per Share
0.010.000.010.010.020.00
Tangible Book Value
1.440.451.441.461.910.31
Tangible Book Value Per Share
0.010.000.010.010.020.00
Updated Aug 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.